Email
USA TODAY panel says US has nailed the science behind COVID-19 vaccines, but logistics, trust remain a concern
Experts are concerned some won t trust the COVID-19 vaccine and are wary of production problems that could delay getting it to millions of Americans.
Karen Weintraub and Elizabeth Weise, USA TODAY
Published
12:12 am UTC Dec. 24, 2020
Experts are thrilled about the reported safety and effectiveness of two COVID-19 vaccines rolling out across the country. But they remain concerned about what still could go wrong to shake the public s fragile faith in it.
Nearly everything about the process has gone well so far, shepherded by the Trump administration s Operation Warp Speed.
Spotlight: Flawed distribution formula in U S means most vulnerable may not get COVID vaccine in time - Xinhua xinhuanet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from xinhuanet.com Daily Mail and Mail on Sunday newspapers.
2020-12-23 04:35:47 GMT2020-12-23 12:35:47(Beijing Time) Xinhua English
WASHINGTON, Dec. 22 (Xinhua) Even though two types of COVID vaccines have been granted emergency use in the United States and one of them has started to be injected to health care workers, a flawed distribution formula may result in those most vulnerable to the coronavirus unable to get vaccinated in time.
The United States has a hierarchical system for vaccination where health care workers are the first in line to be inoculated, but the allocation of vaccines across states is based on the number of adults in each state, meaning health care workers in certain states may end up getting their doses later than those deemed lower priority in other states.